CompletedNCT01570699

Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Florence VORSPAN, MD, MSC
Assistance Publique - Hôpitaux de Paris
Intervention
COMT polymorphism(genetic)
Enrollment
87 target
Eligibility
35 years · All sexes
Timeline
20122016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01570699 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials